Education
About Us
Working with TipRanks
Follow Us
National Health Investors (NHI)
NYSE:NHI
RESEARCH TOOLSreports
Total Valuation
National Health Investors has a market cap or net worth of $3.54B. The enterprise value is $4.29B.
Market Cap$3.54B
Enterprise Value$4.29B
Share Statistics
National Health Investors has 46,693,092 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding46,693,092
Owned by Insiders4.66%
Owned by Institutions0.31%
Financial Efficiency
National Health Investors’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 7.37%.
Return on Equity (ROE)0.10
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)7.37%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee8.57M
Profits Per Employee4.55M
Employee Count30
Asset Turnover0.10
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of National Health Investors is 22.04. National Health Investors’s PEG ratio is 68.98.
PE Ratio22.04
PS Ratio0.00
PB Ratio2.22
Price to Fair Value2.22
Price to FCF14.62
Price to Operating Cash Flow14.62
PEG Ratio68.98
Income Statement
In the last 12 months, National Health Investors had revenue of 257.05M and earned 137.87M in profits. Earnings per share was 3.14.
Revenue257.05M
Gross Profit257.05M
Operating Income214.80M
Pretax Income136.59M
Net Income137.87M
EBITDA264.16M
Earnings Per Share (EPS)3.14
Cash Flow
In the last 12 months, operating cash flow was 208.17M and capital expenditures -7.58M, giving a free cash flow of 200.59M billion.
Operating Cash Flow208.17M
Free Cash Flow200.59M
Free Cash Flow per Share4.30
Dividends & Yields
National Health Investors pays an annual dividend of $0.899, resulting in a dividend yield of 4.74%
Dividend Per Share$0.899
Dividend Yield4.74%
Payout Ratio93.16%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.46
52-Week Price Change24.07%
50-Day Moving Average73.13
200-Day Moving Average73.23
Relative Strength Index (RSI)58.91
Average Volume (3m)242.21K
Important Dates
National Health Investors upcoming earnings date is Aug 11, 2025, TBA Not Confirmed.
Last Earnings DateMay 5, 2025
Next Earnings DateAug 11, 2025
Ex-Dividend DateMar 31, 2025
Financial Position
National Health Investors as a current ratio of 92.80, with Debt / Equity ratio of 83.87%
Current Ratio92.80
Quick Ratio92.80
Debt to Market Cap0.38
Net Debt to EBITDA4.25
Interest Coverage Ratio3.83
Taxes
In the past 12 months, National Health Investors has paid -1.27M in taxes.
Income Tax-1.27M
Effective Tax Rate>-0.01
Enterprise Valuation
National Health Investors EV to EBITDA ratio is 15.75, with an EV/FCF ratio of 20.02.
EV to Sales16.18
EV to EBITDA15.75
EV to Free Cash Flow20.02
EV to Operating Cash Flow20.02
Balance Sheet
National Health Investors has $24.29M in cash and marketable securities with ― in debt, giving a net cash position of $1.12B billion.
Cash & Marketable Securities$24.29M
Total Debt―
Net Cash$1.12B
Net Cash Per Share$24.02
Tangible Book Value Per Share$31.59
Margins
Gross margin is 79.69%, with operating margin of 83.56%, and net profit margin of 53.63%.
Gross Margin79.69%
Operating Margin83.56%
Pretax Margin53.14%
Net Profit Margin53.63%
EBITDA Margin102.77%
EBIT Margin74.97%
Analyst Forecast
The average price target for National Health Investors is $81.80, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$81.80
Price Target Upside7.82% Upside
Analyst ConsensusModerate Buy
Analyst Count5
Revenue Growth Forecast4.88%
EPS Growth Forecast0.41%